Tag Archives: Screening Tests

Screening Tools for Dementia and Cognitive Impairment in Hospitals: Validity and Accuracy (PLoS One)

Posted on July 30, 2019 by Dementia and Elderly Care News

Summary A Swiss systematic review investigated the diagnostic accuracy and validity of various tools for screening dementia and / or cognitive impairment in hospital patients. The aim was to provide up-to-date evidence for the choice of cognitive tests best suited … Continue reading →

Earlier Diagnosis of Alzheimer’s Disease Using Saliva Test? (NHS Choices / JAD)

Posted on May 25, 2017 by Dementia and Elderly Care News

Summary Pilot research indicates that a chemical in the saliva can be used to differentiate, with relatively high accuracy, between persons who are currently healthy, those with mild cognitive impairment (MCI), and others with Alzheimer’s Disease. Potentially, salivary biomarkers could … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Universal Interest | Tagged 1H NMR-Based Metabolomics, Alzheimer’s Disease Biomarkers, Alzheimer’s Early Screening, Beaumont Health, Beaumont Research Institute: Beaumont Health, Behind the Headlines, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Canada, Dementia Saliva Testing (Pilot Study), Dementia Screening, Departments of Biological and Computing Sciences: University of Alberta, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Diagnosis of Alzheimer’s Disease Using Saliva, Fred A. and Barbara M. Erb Family Foundation, JAD, Journal of Alzheimer's Disease, MCI: Mild Cognitive Impairment, Metabolomics, Mild Cognitive Impairment (MCI), NHS Digital (Previously NHS Choices), Non-Invasive Biomarkers, Nuclear Magnetic Resonance Spectroscopy (NMR), Oakland University, Potential for Metabolomics and Saliva in Early Diagnosis of Alzheimer’s Disease, Preclinical Biomarkers and Dementia, Preclinical Biomarkers in Alzheimer's Disease, Saliva, Saliva Tests, Salivary Biomarkers, Screening, Screening for Dementia, Screening Tests, Surrogate Biomarkers of Neurodegeneration, United States, University of Alberta, USA, William Beaumont School of Medicine: Oakland University | Leave a comment

Questioning the Disproportionate Flood of Publications Praising the Benefits of Early Detection: Too Much of a Good Thing? (BMJ)

Posted on May 10, 2017 by Dementia and Elderly Care News

Summary A brief Norwegian review has highlighted an unbalanced surge in publications about the benefits of the earlier detection of diseases (which are typically taken unquestioningly as a “given”). The authors allege that articles discussing the benefits of early detection … Continue reading →

Posted in Acute Hospitals, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Person-Centred Care, Quick Insights, Statistics, Universal Interest | Tagged Benefits of Early Detection, BMJ, BMJ Publishing Group Ltd, Department of Health Sciences in Gjøvik: Norwegian University of Science and Technology, Department of Public Health and Nursing: Norwegian University of Science and Technology, Early Detection of Disease, Early Diagnosis, Early Screening, General Health Checks in Adults, Harms From Overdiagnosis, Harms of Too Much Medicine, Health Screening Programmes, Improving Patient Safety, Improving Value in Diagnostic Services, Incentivised GP Health Checks, Lean and Quality Improvement, Less is More, Lowering Costs, Medical and Surgical Overtreatment, Medical Overuse, Medicalisation, Medicalising Unhappiness, Norway, Norwegian University of Science and Technology, Over-Diagnosis, Over-Medicalisation (Speculative Concept), Over-Treatment, Overdiagnosis and Overtreatment, Overuse of Diagnostic or Monitoring Tests / Procedures, Overuse of Medication, Patient Harms, Patient Safety, Protecting Resources and Promoting Value, Reducing Expenditure, Reducing Productive Waste, Screening, Screening Populations, Screening Programmes, Screening Tests, Timely Diagnosis, Too Much Medicine, Unnecessary Tests | Leave a comment

Under-Diagnosis of Dementia in the Community: an International Review (BMJ Open / JGCR)

Posted on February 8, 2017 by Dementia and Elderly Care News

Summary A literature review and meta-analysis of 23 international studies on the under-detection (i.e. the failure to achieve a diagnosis) of dementia identified a pooled rate of undetected dementia assessed to be 61.7%. The rate of under-detection was higher in … Continue reading →

Posted in Acute Hospitals, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), International, Models of Dementia Care, Quick Insights, Royal Wolverhampton NHS Trust, Royal Wolverhampton NHS Trust Authorial Affiliation, Statistics, UK, Universal Interest, Wolverhampton | Tagged Academic Institute of Medicine: University of Wolverhampton, Affluence and Health Inequalities, Age and Gender Differences in Diagnosis Rates, Agewell Foundation (India), Anhui Medical University, Assessment and Diagnosis, Australia, Australian National University, Barriers to Early Diagnosis, BMJ Open, BMJ Publishing Group Ltd, Case Finding, Case Finding for Patients with Dementia, Centre for Research on Ageing Health and Wellbeing: Australian National University, China, Cognitive Assessment Tools, Cognitive Impairment, Dementia Case Finding, Dementia Case Finding Scheme, Dementia Challenge, Dementia Collaborative Research Centre-Early Diagnosis and Prevention: Australian National University, Dementia Diagnosis, Dementia Screening, Dementia Screening Debate, Department of Practice and Policy: University College London, Department of Psychiatry: University of Liverpool, Department of Public Health: Wolverhampton City Council, Diagnosis and Referral, Diagnosis and Support, Diagnosis at Primary Care Level, Diagnosis Gap, Diagnosis of Dementia, Diagnosis Rates, Dignity Foundation (India), Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Screening, Effectiveness of Early Detection and Treatment, Ethical Considerations, Ethical Dilemmas, Ethical Issues of Dementia Care, Ethics and Decision-Making, Europe, Faculty of Education Health and Wellbeing: University of Wolverhampton, General Practice, Geriatric Care and Research Organisation (GeriCaRe), GPs, Health Inequalities, HelpAge India, India, Journal of Geriatric Care and Research (JGCR), Liverpool, Mental Health Inequalities, Mini Mental State Examination (MMSE), National Programme for the Health Care of the Elderly (NPHCE), New Cross Hospital: Royal Wolverhampton NHS Trust, North America, Post Graduate Academic Institute of Medicine: University of Wolverhampton, Reducing Health Inequalities, Research School of Population Health: Australian National University, Royal Wolverhampton NHS Trust, School of Health Administration: Anhui Medical University, Screening, Screening for Cognitive Impairment, Screening for Cognitive Impairment in Older Adults, Screening for Dementia, Screening Programmes, Screening Tests, Socio-Economic Differences in Diagnosis Rates, Timely Diagnosis, UK National Screening Committee (UK NSC), Under-Detection of Dementia, University College London, University of Liverpool, University of Wolverhampton, Wolverhampton City Council | 1 Comment

Choosing Wisely: A New Review of Overdiagnosis and Overtreatment (BBC News / Academy of Medical Royal Colleges / BMJ)

Posted on October 24, 2016 by Dementia and Elderly Care News

Summary Continuing the debate concerning avoidable overuse in medical care, the Academy of Medical Royal Colleges has drawn-up a list of forty treatments which are thought to confer little or no benefit to patients. Full Text Link Reference Doctors name … Continue reading →

Posted in BBC News, Commissioning, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, Management of Condition, National, NHS, Person-Centred Care, Personalisation, Practical Advice, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged Academy of Medical Royal Colleges (AoMRC), Achieving Better Value, Approaches to Quantifying Overdiagnosis, BBC Health News, Better Value, Better Value Healthcare, Better Value in the NHS, BMJ Publishing Group Ltd, British Medical Journal (BMJ), Broadening of Disease Definitions, Choosing Wisely, Choosing Wisely Campaign, Choosing Wisely in the NHS, CIPFA, Clinical Responsibility for Patients (Choosing Wisely and New Deal), Department of Medicine and Center for Health Policy and Outcomes: Memorial Sloan Kettering Cancer Cente, Division of General Internal Medicine: Icahn School of Medicine at Mount Sinai, Drivers of Overdiagnosis, Estimated Proportions of Cancers Representing Likely Overdiagnosis, False Positives, Financial Incentives for Screening and Testing, Financial Sustainability in the NHS, Forty Treatments With Little or No Benefit For Patients (Academy of Medical Royal Colleges), Great Prostate Mistake, Great Prostate Mistake (PSA sic Promoting Stress and Anxiety), Harms From Overdiagnosis, Harms of Too Much Medicine, Health Screening Programmes, Icahn School of Medicine at Mount Sinai (New York), Improving Patient Safety, Improving Prescribing Practice, Improving Value in Diagnostic Services, Labeling, Labeling of Patients, Lack of Clarity Regarding Disease Severity Spectrum, Lean and Quality Improvement, Less is More, Lowering Costs, Lowering of Diagnostic Thresholds, Medical Overuse, Memorial Sloan-Kettering Cancer Center: New York, Overdiagnosis and Overtreatment, Overdiagnosis in Context of Benefits and Harms of Prostate Cancer Screening, Overdiagnosis in Primary Care, Overestimation of Benefit of Therapy in Mild or Low Risk Disease, Overmedicalization, Overuse of Diagnostic or Monitoring Tests / Procedures, Overuse of Medication, Patient Harms, Patient Safety, Prostate Cancer Screening, Protecting Resources and Promoting Value, Quantifying Overdiagnosis, Reducing Expenditure, Reducing Inappropriate Laboratory Investigations, Reducing Inappropriate Polypharmacy, Reducing Prescribing Costs, Reducing Productive Waste, Reducing Waste in the NHS, Screening and Overdiagnosis in Primary Care, Screening Programmes, Screening Tests, Terms Related to Overdiagnosis, Too Much Medicine, Unnecessary Tests, Value for Money, Value Improvement, Valueing Diagnosis for Own Sake | Leave a comment

Screening For Frailty: as Easy as eFI? (NHS England / Age and Ageing)

Posted on September 20, 2016 by Dementia and Elderly Care News

Summary The “electronic Frailty Index (eFI)” is discussed, by NHS England’s National Clinical Director for Older People and Person Centred Integrated Care, as a validated tool which might assist in the proactive identification, diagnosis and management of frailty. Potentially, the … Continue reading →

Posted in Commissioning, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, National, NHS, NHS England, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, Statistics, Systematic Reviews, UK, Universal Interest | Tagged Academic Unit of Elderly Care and Rehabilitation: University of Leeds, Age and Ageing, Ageing and Long-Term Care: Projections, Ageing Population, Ageing Research, Amenable Mortality, Avoidable Hospital Admissions, Avoidable Mortality, Avoidable Premature Mortality, Avoidable Rehospitalisations, BMJ Open, BMJ Publishing Group Ltd, Bradford, British Geriatrics Society, Care for Vulnerable Older People, Care Home Admission Delay, Care of Frail Older People With Complex Needs, Centre for Reviews and Dissemination: University of York, Charlson Comorbidity Index, Commissioning for Older People, Connected Bradford, Connected Health Cities, Count-Based Multimorbidity Measures, Cumulative Deficit Frailty Model, Cumulative Deficit Model, Deficits Contained in eFI Calculations, Disease Counts, Dr Martin Vernon: Consultant Geriatrician and Associate Head of Division for Medicine and Community Services for Central Manchester, Dr Martin Vernon: National Clinical Director for Older People and Integrated Care, Dr Martin Vernon: NCD for Older People and Integrated Person Centred Care, Dublin, Effectiveness Matters, Electronic Frailty Index, electronic Frailty Index (eFI), Electronic Health Records, Electronic Health Records (EHRs), Faculty of Health Studies: University of Bradford, Frail Older People, Frailty, Frailty Identification and Frailty Care, Frailty Services, Frailty Syndromes, Functional Decline, General Practice, General Practices, General Practitioners, GP Assessment, Guidance on Supporting Routine Frailty Identification and Frailty Care Through the GP Contract 2017/2018, Holistic Medical Reviews (Automated Electronic Heuristics), Holistic Medical Reviews by GPs, HRB Centre for Primary Care Research: Royal College of Surgeons in Ireland (RCSI), Identification of Frailty, Identification of Frailty (Routine Screening), Identifying People Living With Frailty, Identifying Vulnerable People, Improving Care for Frail Older People, Improving General Practice, Improving Quality in General Practice, Improving the Quality of Care in General Practice, Inappropriate Hospital Admissions, Independence at Home, Institute of Applied Health Research: University of Birmingham, Ireland, John Young: Academic Unit of Elderly Care and Rehabilitation at University of Leeds, Long-Term Care and Support, Long-Term Conditions (LTCs), Maintaining Independence, Medication Counts, Mortality in Older People, Mortality Morbidity and Wellbeing, Multimorbidity Measures, Older Community-Dwelling Adults, Older People At Home, Opportunities to Treat Patients Without Hospital Admission, Pathways for Frail and Vulnerable People, People Living With Frailty, Point-of-Care Screening, Population Health Sciences Division: Royal College of Surgeons of Ireland (RCSI), Preventable Hospital Admissions, Primary Care, Professor John Young, Professor John Young: Former National Clinical Director for Integration and Frail Elderly at NHS England, Rapid Screening, Recognising and Managing Frailty in Primary Care, Reducing Unplanned Hospitalisation, Rehospitalisations, ResearchOne (TPP Leeds West Yorkshire), ResearchOne Health and Care Database, ResearchOne Primary Care Database, Risk of Nursing Home Admission, Routine Primary Care Electronic Health Record Data, Royal College of Surgeons of Ireland (RCSI), RxRisk-V, Screening, Screening For Frailty, Screening Tests, Selected Conditions Counts, Shakespeare: Seven Ages of Man, Staying Independent, Supporting Older People Living With Frailty in the Community, Supporting People With Hospital Admissions, Supporting Vulnerable People, SystmOne (TPP Leeds West Yorkshire), SystmOne Electronic Health Record System, Targeted Screening, Targeting Resources on Vulnerable Populations, The Health Improvement Network (THIN) Databases, THIN Database, Toolkit for General Practice in Supporting Older People Living With Frailty (NHS England), TPP SystmOne Clinical System, Treating Patients Without Hospital Admission, University of Leeds, University of York, Unnecessary Hospital Admissions, Unplanned Hospital Admissions, Unplanned Hospitalisation, Validation of electronic Frailty Index (eFI), Vulnerable Adults, West Yorkshire, Yorkshire and Humber AHSN Improvement Academy | Leave a comment

The Pros and Cons of Screening (Sense About Science / BMJ / BMC Geriatrics / BBC News / NHS England)

Posted on July 19, 2015 by Dementia and Elderly Care News

Summary The brief “Making Sense of Screening” guide attempts to inform public expectations about screening programmes. It offers insights into the limitations of what screening programmes are sometimes able to deliver. Common misconceptions about how screening works are addressed, with … Continue reading →

Posted in BBC News, Charitable Bodies, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Models of Dementia Care, Quick Insights, UK, Universal Interest | Tagged Academic Unit of Psychiatry: University of Bristol, Advisory Board of Breast Screening, Association for Clinical Biochemistry and Laboratory Medicine, BBC Health News, BMJ, British Medical Journal (BMJ), Cambridge Institute of Public Health: University of Cambridge, Case Finding, Cognitive Screening, Dementia Screening, Dementia Screening Debate, Division of Psychiatry: University College London, Early Screening, Evidence Based Medicine Matters, Faculty of Medicine and Health Sciences: University of East Anglia, False Alarms, False Negatives, False Positives, Great Prostate Mistake, Great Prostate Mistake (PSA sic Promoting Stress and Anxiety), Harms From Overdiagnosis, Health Screening Programmes, Hedley Glencross: Portsmouth Hospitals NHS Trust, Independent Review of Adult Screening Programme in England (NHS England), Institute of Biomedical Science, Institute of Mental Health: University of Nottingham, International Journal of Geriatric Psychiatry, Joe O’Meara: Association for Clinical Biochemistry and Laboratory Medicine, Making Sense of Testing, Making Sense of Uncertainty, Mass Screening, National Breast Cancer Screening Programme, National Screening Committee, Nordic Cochrane Centre in Copenhagen, Overdiagnosis (Speculative Concept), Overdiagnosis and Overtreatment, Population Screening for Dementia Deyond Passive Case-Finding, Professor Sir Mike Richards: Review of Cancer Screening, PSA (Prostate Specific Antigen), Public Attitudes Expectations and Preferences, QRISK2 Calculator, Research Department of Primary Care and Population Health: University College London, Review of National Cancer Screening Programmes in England, Risk of Overdiagnosis Associated With Screening, Síle Lane: Sense About Science, Screening, Screening for Dementia, Screening Populations, Screening Programmes, Screening Tests, Screening: Counter-Intuitive Evidence, Sense About Science, Targeted Screening, UCL Medical School, UK National Screening Committee, University College London, University of Bristol, University of Cambridge, University of East Anglia, University of Nottingham, Watchful Waiting | Leave a comment

Literature Review on Olfaction (Sense of Smell) and Neurodegenerative Diseases (International Archives of Otorhinolaryngology)

Posted on May 30, 2015 by Dementia and Elderly Care News

Summary Loss of sense of smell may be involved in certain neurodegenerative diseases, including Parkinson Disease and Alzheimer’s Disease. This literature review examines the relationships between olfactory dysfunction and neurological / neurodegenerative diseases. Olfactory tests may have a role in … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Parkinson's Disease, Quick Insights | Tagged Alzheimer’s Early Screening, Brazil, Dementia Screening, Department of Otorhinolaryngology: Faculdade de Medicina da Universidade de São Paulo, Early Screening, Faculdade de Medicina da Universidade de São Paulo, fMRI, Functional Magnetic Resonance Imaging (fMRI), Gender Differences in Human Olfactory Bulb, International Archives of Otorhinolaryngology, Loss of Sense of Smell, Neurodegeneration, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Olfaction (Sense of Smell), Olfaction and Neurodegenerative Diseases, Olfactory Discrimination and Cognitive Decline, Olfactory Dysfunction, Olfactory Epithelium Biopsy, Olfactory Tau Pathology in Alzheimer's Disease, Olfactory Tests, Olfactory Vector (Risk Factor) Hypothesis in Neurodegenerative Disease, Screening Tests | Leave a comment

National Screening for Dementia Not Recommended (UK NSC / AHRQ / Annals of Internal Medicine / Epidemiology / International Journal of Epidemiology)

Posted on January 19, 2015 by Dementia and Elderly Care News

Summary The UK National Screening Committee (UK NSC) has upheld previous recommendations against screening people aged 65 and over for dementia. This decision follows an extensive review of the evidence. The UK NSC has concluded that tests for dementia, which … Continue reading →

Screening for Cognitive Impairment in Older Adults (USPSTF)

Posted on July 30, 2014 by Dementia and Elderly Care News

Summary The U.S. Preventive Services Task Force (USPSTF) recommendations on screening for cognitive impairment / dementia have been updated. USPSTF concludes that the evidence remains insufficient to assess the balance of benefits and harms regarding screening for cognitive impairment in … Continue reading →

Posted in Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Quick Insights, Systematic Reviews | Tagged Agency for Healthcare Research and Quality (AHRQ), Agency for Healthcare Research and Quality (US), Alzheimer’s Early Screening, Benefits of Detection and Early Intervention, Case Finding, Case Finding for Patients with Dementia, Cognition Disorders, Cognitive Impairment, Dementia Case Finding, Dementia Screening, Dementia Screening Debate, Early Diagnosis, Early Screening, Effectiveness of Early Detection and Treatment, Harms of Detection and Early Intervention or Treatment, Mass Screening, Neuropsychological Tests, Risk Assessment, Screening for Cognitive Impairment, Screening for Cognitive Impairment in Older Adults, Screening Programmes, Screening Tests, Targeted Screening, U.S. Preventive Services Task Force (USPSTF), United States, United States Preventive Services Task Force, USA | Leave a comment

Tag Archives: Screening Tests

Screening Tools for Dementia and Cognitive Impairment in Hospitals: Validity and Accuracy (PLoS One)

Earlier Diagnosis of Alzheimer’s Disease Using Saliva Test? (NHS Choices / JAD)

Questioning the Disproportionate Flood of Publications Praising the Benefits of Early Detection: Too Much of a Good Thing? (BMJ)

The Pros and Cons of Screening (Sense About Science / BMJ / BMC Geriatrics / BBC News / NHS England)

Literature Review on Olfaction (Sense of Smell) and Neurodegenerative Diseases (International Archives of Otorhinolaryngology)

National Screening for Dementia Not Recommended (UK NSC / AHRQ / Annals of Internal Medicine / Epidemiology / International Journal of Epidemiology)

Screening for Cognitive Impairment in Older Adults (USPSTF)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites